The Annals Evolution of Clinical Pharmacy | Now Available
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     


Published Online, 19 October 2004, www.theannals.com, DOI 10.1345/aph.1E225.
 The Annals of Pharmacotherapy: Vol. 38, No. 12, pp. 2055-2058. DOI 10.1345/aph.1E225
© 2004 Harvey Whitney Books Company.
This Article
Right arrow Résumé Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Köklü, S.
Right arrow Articles by Arhan, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Köklü, S.
Right arrow Articles by Arhan, M.

Probable Sulbactam/Ampicillin–Associated Prolonged Cholestasis

Seyfettin Köklü, MD

Specialist, Department of Gastroenterology, Türkiye Yüksek Ihtisas Hospital, Ankara, Turkey

Aydin S Köksal, MD

Specialist, Department of Gastroenterology, Türkiye Yüksek Ihtisas Hospital

Mehmet Asil, MD

Specialist, Department of Gastroenterology, Türkiye Yüksek Ihtisas Hospital

Halil Kiyici, MD

Specialist, Department of Pathology, Baskent University, Konya Research and Practice Hospital, Konya, Turkey

Sahin Çoban, MD

Research Fellow, Department of Gastroenterology, Ankara University Medical School, Ankara

Mehmet Arhan, MD

Specialist, Department of Gastroenterology, Türkiye Yüksek Ihtisas Hospital

Reprints: Seyfettin Köklü MD, Tip Fakültesi caddesi, 259 / 3, Mamak, Ankara, Turkey, fax 90-312-3124120, gskoklu{at}yahoo.com

OBJECTIVE: To present a single case of sulbactam/ampicillin–induced chronic cholestasis and a literature review of antibiotic-associated chronic cholestasis.

CASE SUMMARY: A 74-year-old man with Hodgkin's disease in remission developed severe and prolonged cholestasis after treatment with sulbactam/ampicillin 750 mg twice daily for 7 days. All other etiologies, including Hodgkin's disease, were appropriately ruled out and the cholestasis was ascribed to sulbactam/ampicillin treatment. The patient improved gradually and became asymptomatic 7 months after the last dose of sulbactam/ampicillin. According to the Naranjo probability scale, sulbactam/ampicillin was the probable cause of the cholestasis.

DISCUSSION: Ampicillin, a semisynthetic penicillin, has rarely been associated with hepatic injury when used alone. Hepatocellular and acute cholestatic injury due to ampicillin have been described. Cholestasis secondary to sulbactam/ampicillin use has not been previously reported.

CONCLUSIONS: Sulbactam/ampicillin, one of the most widely used antibiotics, may cause chronic cholestatic hepatitis. Clinicians should be aware of this adverse affect and consider it during diagnostic workup of liver injury.

Key Words: antibiotics, cholestasis, drug-related liver injury, hepatotoxicity, sulbactam/ampicillin

Published Online, October 19, 2004. www.theannals.com, DOI 10.1345/aph.1E225




homecopy help contact us subscription past issues search current issue
Copyright © 2004 by Harvey Whitney Books Company.